WO2006079185A1 - Apparatus and method for monitoring cell motility - Google Patents
Apparatus and method for monitoring cell motility Download PDFInfo
- Publication number
- WO2006079185A1 WO2006079185A1 PCT/AU2006/000116 AU2006000116W WO2006079185A1 WO 2006079185 A1 WO2006079185 A1 WO 2006079185A1 AU 2006000116 W AU2006000116 W AU 2006000116W WO 2006079185 A1 WO2006079185 A1 WO 2006079185A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- chemical agent
- viewing surface
- cell
- chamber
- aperture
- Prior art date
Links
- 238000012544 monitoring process Methods 0.000 title claims abstract description 33
- 230000009087 cell motility Effects 0.000 title claims abstract description 32
- 238000000034 method Methods 0.000 title claims description 17
- 239000013043 chemical agent Substances 0.000 claims abstract description 104
- 239000012530 fluid Substances 0.000 claims abstract description 26
- 230000004044 response Effects 0.000 claims abstract description 13
- 238000004891 communication Methods 0.000 claims abstract description 7
- 239000000758 substrate Substances 0.000 claims description 46
- 230000004888 barrier function Effects 0.000 claims description 23
- 238000010276 construction Methods 0.000 claims description 12
- 230000004899 motility Effects 0.000 claims description 6
- 210000004027 cell Anatomy 0.000 description 74
- 239000002609 medium Substances 0.000 description 21
- 206010028980 Neoplasm Diseases 0.000 description 9
- 201000011510 cancer Diseases 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- 210000000440 neutrophil Anatomy 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 4
- 241000224495 Dictyostelium Species 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- VUDQSRFCCHQIIU-UHFFFAOYSA-N 1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl)hexan-1-one Chemical compound CCCCCC(=O)C1=C(O)C(Cl)=C(OC)C(Cl)=C1O VUDQSRFCCHQIIU-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 210000003719 b-lymphocyte Anatomy 0.000 description 2
- 210000003651 basophil Anatomy 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 210000002889 endothelial cell Anatomy 0.000 description 2
- 210000003979 eosinophil Anatomy 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 210000003630 histaminocyte Anatomy 0.000 description 2
- 238000000651 laser trapping Methods 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 210000001616 monocyte Anatomy 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000010865 video microscopy Methods 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- 241000157881 Acrasis rosea Species 0.000 description 1
- 241000224489 Amoeba Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000168726 Dictyostelium discoideum Species 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000003181 biological factor Substances 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000002975 chemoattractant Substances 0.000 description 1
- 230000010002 chemokinesis Effects 0.000 description 1
- 230000003609 chemorepellent Effects 0.000 description 1
- 239000002838 chemorepellent Substances 0.000 description 1
- 230000003399 chemotactic effect Effects 0.000 description 1
- 230000035605 chemotaxis Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000035926 haptotaxis Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 238000000059 patterning Methods 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 210000000844 retinal pigment epithelial cell Anatomy 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502746—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by the means for controlling flow resistance, e.g. flow controllers, baffles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502715—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5029—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on cell motility
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/02—Adapting objects or devices to another
- B01L2200/026—Fluid interfacing between devices or objects, e.g. connectors, inlet details
- B01L2200/027—Fluid interfacing between devices or objects, e.g. connectors, inlet details for microfluidic devices
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0816—Cards, e.g. flat sample carriers usually with flow in two horizontal directions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0475—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure
- B01L2400/0487—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure fluid pressure, pneumatics
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/08—Regulating or influencing the flow resistance
- B01L2400/084—Passive control of flow resistance
- B01L2400/086—Passive control of flow resistance using baffles or other fixed flow obstructions
Definitions
- Cell motility in response to a chemical agent is fundamentally important in many biological processes such as cancer metastasis , embryogenesis and wound healing .
- the study of cell motility in response to specific chemical agents can lead to the identification of agents or receptors for the agents which are potential therapeutic targets for use in the treatment of wounds, cancer and inflammation .
- cells capable of motility including bacteria, protozoa, amoeba, cellular slime moulds ( Dictyostelium discoideum) , fungi , sperm, fibroblasts , phagocytes , cancer cells , neurons , epithelial cells , endothelial cells , and cells of the immune system including mast cells , neutrophils , lymphocytes , monocytes , macrophages , leukocytes , T-cells , B-cells , eosinophils and basophils .
- bacteria protozoa
- amoeba cellular slime moulds
- fungi fungi
- sperm fibroblasts
- phagocytes cancer cells
- neurons neurons
- epithelial cells endothelial cells
- cells of the immune system including mast cells , neutrophils , lymphocytes , monocytes , macrophages , leukocytes , T-cells ,
- neutrophils and Dictyostelium are typically fast moving and are able to maintain a direction of movement once determined even if concentrations of a chemical agent fluctuate .
- cancer cells typically move 10-15 times slower than cells , such as neutrophils and Dictyostelium, and lack the ability to maintain a direction of movement and will often make numerous changes in direction of movement under conditions of fluctuating concentrations of the chemical agent .
- the most informative way to study cell motility is through monitoring the motility cycle of a cell in response to a chemical agent of interest .
- an apparatus for monitoring cell motility in response to a chemical agent comprising a chamber for containing a medium; a cell viewing surface arranged in the chamber so as to be submersed in the medium when in use; a fluid delivery arrangement in communication with the chamber for delivering the chemical agent to a portion of the cell viewing surface; wherein the fluid delivery arrangement is arranged relative to the cell viewing surface for directing the chemical agent such that, when monitoring cell motility, the chemical agent assumes a concentration gradient in relation to the cell viewing surface portion .
- the apparatus may be used for monitoring any type of cell motility in response to a chemical agent .
- Cell motility includes , but is not limited to chemotaxis , haptotaxis , chemokinesis , motility by contact priming (with substrate patterning) and invasion .
- the term "chemical agent” as used herein refers to any type of agent to which a cell may respond .
- the chemical agent may be synthetic, for example a drug or drug compound .
- the chemical agent may be a biological factor, for example a sugar, amino acid, peptide or protein .
- the chemical agent may be a chemoattractant and chemorepellent or a chemotactic agent .
- the chamber of the apparatus may be made from any material suitable for monitoring cell motility in response to a chemical agent .
- the chamber is made from an optically transparent material suitable for use with video microscopy .
- the chamber may be made from glass or plastic .
- the chamber can contain a medium suitable to monitoring cell motility .
- the medium may be a liquid medium.
- the medium may be a matrix .
- the matrix is a gel .
- the gel may comprise collagen, fibronectin, other connective tissue matrix components , other naturally-derived and tumour-derived matrix .
- the medium may be a buffer such as MEM, DMEM, L15 , RPMI , HEPES-buffered medium.
- the cells to be monitored are placed onto the cell viewing surface , with the cell viewing surface being arranged so as to be submersed in the medium.
- the apparatus is suitable for monitoring any cell type .
- Examples of cell types that may be monitored using the apparatus include but are not limited to cancer cells , spermatozoa, bacteria, fungi , epithelial cells , neurons , endothelial cells , fibroblasts , mast cells , neutrophils , dictyostelium cells , lymphocytes , monocytes , macrophages , leukocytes , T-cells , B-cells , eosinophils , basophils and combinations thereof .
- the fluid delivery arrangement of the apparatus can be arranged in any configuration relative to the cell viewing surface provided that the configuration is suitable for directing the chemical agent such that, when monitoring cell motility, the chemical agent assumes a concentration gradient in relation to the cell viewing surface portion .
- the fluid delivery arrangement comprises one or more apertures arranged to release the flow of the chemical agent to the medium in the vicinity of the cell viewing surface portion .
- the one or each aperture can have a configuration that influences a direction to the flow of chemical agent through the aperture .
- the side wall of the one or each aperture may influence a direction to the flow of chemical agent through the aperture .
- the apertures may be located at any position relative to the cell viewing surface portion provided they are capable of releasing the flow of the chemical agent to the medium in the vicinity of the cell viewing surface portion .
- the apertures may be located in the cell viewing surface .
- the fluid delivery arrangement may further comprise a barrier construction arranged relative to the cell viewing surface portion such that, when a flow of chemical agent is delivered by the fluid delivery arrangement via the one or more apertures to the cell viewing surface portion, the flow interacts with the barrier construction to impart the concentration gradient .
- the barrier construction diverts the flow of chemical agent to impart the concentration gradient .
- diverting the flow of chemical agent modulates any one or more of the following : the rate at which the gradient is formed; the steady-state shape of the gradient; the stability of the gradient; the steepness of the gradient .
- the barrier can be defined by a physical means such as a dam.
- the barrier can be defined by a photonic means such as through optical trapping . Methods for optical trapping and other photonic means are described in, for example, Dholakia and Reece ( 2006 ) Optical Micromanipulation Takes Hold, Nanotoday VoI 1 ( 1 ) : 18-27 ; Mach, P . et al .
- the barrier can be defined by solid-phase chemistry as described in Lim et al . (2004 ) Retinal Pigment Epithelial Cell Behaviour is Modulated by Alterations in Focal Cell- Substrate Contacts , Investigative Ophthalmology & Visual Science , vol . 45 ( 11 ) : 42i ⁇ -4216 ) .
- the cell viewing surface is a platform that defines a wall in the chamber, with the wall in turn defining the dam.
- the wall may extend across the chamber from one chamber side to the other .
- the fluid delivery arrangement of the apparatus may further comprise one or more conduits in fluid communication with a source for the chemical agent, one or each conduit extending to one or each respective aperture .
- the conduits are one or more channels in a substrate that each extend to a respective aperture positioned in, or in relation to, the substrate .
- the channels can be any dimension suitable for delivery of the chemical agent to the cell viewing surface portion .
- the channels can be as deep as the depth of view of the lowest magnification obj ective lenses and as wide as the width of the chamber .
- the channels are 50 ⁇ m in depth and 50 ⁇ m in width .
- the one or each conduit is defined by a respective one or more micropipettes , with each aperture being defined by an outlet of the respective micropipette .
- the apertures of the apparatus may be any size suitable for directing the chemical agent such that , when monitoring cell motility, the chemical agent assumes a concentration gradient in relation to the cell viewing surface portion .
- the apertures can be as wide as the width of the chamber and as narrow as 0.02 ⁇ m. In one embodiment , the apertures are l ⁇ m in diameter .
- the chemical agent may be delivered to the cell viewing surface portion under pressure .
- the chemical agent may be delivered at a constant and continuous pressure .
- the chemical agent may be delivered under pulsed pressure .
- the chemical agent - may be delivered at any pressure that is suitable for delivering the chemical agent .
- the chemical agent when the chemical agent is delivered at 0 hPa constant pressure, the chemical may diffuse freely into the medium in the chamber .
- the chemical ⁇ agent is delivered at 0 hPa pulsed pressure, backpressure or pressure less than 0 hPa may be applied to stop the flow of chemical agent at intervals .
- the chemical agent is delivered at a pressure of 0 hPa or more .
- the chemical agent is delivered at a pressure of 2OhPa .
- apparatus for monitoring cell motility in response to a chemical agent comprising a chamber for containing a medium; a cell viewing surface arranged in the chamber so as to be submersed in the medium when in use; a fluid delivery arrangement in communication with the chamber for delivering the chemical agent to a portion of the cell viewing surface , the fluid delivery arrangement comprising a barrier construction that is arranged, relative to the cell viewing surface portion, such that when a flow of chemical agent is delivered by the fluid delivery arrangement to the cell viewing surface portion, the flow interacts with the barrier construction to impart a concentration gradient of the chemical agent in the medium.
- the barrier construction of the second aspect may be defined by the aperture wall ( s ) or dam of the first aspect .
- the apparatus of the second aspect may otherwise be as defined as per the first aspect .
- a method for monitoring cell motility in response to a chemical agent in a medium comprising the step of delivering the chemical agent to one or more cells in a manner such that, when monitoring the motility of the one or more cells , the chemical agent has assumed a concentration gradient in the medium.
- the concentration gradient of the chemical agent can be shaped by physically directing the flow of chemical agent to the medium in the vicinity of the one or more cells .
- the flow of the chemical agent is directed through one or more apertures arranged in the medium.
- a side wall of one or each aperture may physically direct the flow of the chemical agent through the aperture .
- the flow of chemical agent interacts with a barrier arranged in the fluid medium to physically direct the flow of the chemical agent .
- the barrier can be defined by a dam.
- the method for monitoring cell motility may be performed using the apparatus as described in the first and second aspects .
- Figure IA shows a perspective view of one form of the apparatus for monitoring cell motility employing a single micropipette ;
- Figure IB shows a side sectional view of the apparatus shown in Figure IA;
- Figure 2A shows a perspective view of the apparatus shown in Figure 1 employing multiple micropipettes 2a;
- Figure 2B shows a perspective view of the apparatus shown in Figure 1 employing a micropipette 2a having a broad tip
- Figure 3 shows a perspective view of another form of the apparatus for monitoring cell motility in which :
- Figure 3A shows a perspective view of an upper substrate 1 containing apertures Ia
- Figure 3B shows a perspective view of a lower substrate 2 containing channels 2a;
- Figure 3C shows a perspective view of the assembled product of surfaces 1 and 2 , with superimposition of the substrates and the upper apertures Ia and lower channels 2a;
- Figure 3D shows an enlarged sectional view of the apparatus shown in Figure 3C showing the relative positions of a single aperture Ia in the upper substrate 1 , and the opening 2b of the channel 2a in the lower substrate 2 ;
- Figure 3E shows an enlarged view of a single aperture of the upper substrate shown in Figure 3A, where the side walls of the aperture direct the flow of chemical agent (the concentration gradient 7 forms at the rim of the aperture and its direction is generally- perpendicular to the vertical flow along the walls of aperture Ib) ;
- Figure 3F shows various alternative embodiments for the configuration of aperture Ia
- Figure 3G shows a perspective view of the apparatus shown in Figure 3C incorporating a single elongate aperture ;
- Figure 3H shows a perspective view of the apparatus shown in Figure 3C in which the alignment of the aperture ( s ) is intermediate the channel ( s ) and not at the channel termini , and where the termini of the channel ( s ) are sealed; and with additional aperture set ( s ) being provided along the length of the channel ;
- Figure 4 shows various embodiments of the apparatus shown in Figure 3 in which : Figure 4A depicts a single channel;
- Figure 4B depicts more than one channel
- Figure 4C depicts more than one channel 2a, each housed in a sub-chamber 3 ;
- Figure 4D depicts groups of more than one channel in a single sub-chamber 3 ;
- Figure 4E depicts groups of channels where each group is housed in its own sub-chamber 3 ;
- Figure 5 shows a perspective view of another form of the apparatus for monitoring cell motility
- Figure 6 shows a plan view of yet another form of the apparatus for monitoring cell motility
- Figure 7 shows a steady-state concentration profile of a chemical agent for the apparatus shown in Figures 1 and 2
- Figure 8 shows a steady-state concentration profile of a chemical agent for the apparatus shown in Figure 3 ;
- Figure 9 shows the concentration gradient of a chemical agent at various pressures .
- FIG. 1 , 2 and 7 one embodiment of an apparatus for monitoring cell motility is shown .
- This embodiment is typically employed for monitoring slow moving cell types , such as cancer cells .
- the apparatus shown comprises a chamber 3 housing two optically-transparent substrates , an upper cell viewing substrate 1 and lower substrate 2 forming a floor of the chamber 3.
- the substrates are approximately 100 microns in thickness ( t ) .
- the substrates 1 , 2 are bonded together either permanently or non-permanently to form a sealed unit .
- the wall Ia of the cell viewing surface 1 defines a dam extending across the chamber from one side to the other .
- One or more micropipettes 2a extend to an aperture in the form of a distal outlet of the micropipette, which in use is positioned to abut the dam Ia .
- the outlet diameter of the micropipette is typically 0.5 ⁇ m.
- each micropipette can also be held in place against dam wall Ia via a suitable adj ustable j ig .
- the cells to be monitored are seeded onto an upper surface of the cell viewing substrate 1 , and the chamber filled with a suitable buffer .
- the micropipette ( s ) 2a is filled with a chemical agent and then positioned at a 40° angle ( ⁇ ) to the dam Ia .
- the 40° angle has been found to be optimal for concentration gradient generation in the apparatus depicted, but of course can and may vary with chamber variation .
- the micropipette ( s ) is lowered into the chamber 3 , manoeuvred onto the upper surface of the cell viewing substrate 1 , drawn over the edge, lowered to a distance (H) of 17 ⁇ m from the top edge of the cell viewing substrate 1 and pushed gently against the side of the wall Ia .
- H a distance of 17 ⁇ m from the top edge of the cell viewing substrate 1 and pushed gently against the side of the wall Ia .
- the micropipette ( s ) are then connected to a compressor (not shown) , for example a Femtoj et micromanipulator 5171 (Eppendorf) compressor .
- the compressor produces an adj ustable, continuous pressure ( P) of approximately 20 hPa .
- P adj ustable, continuous pressure
- This pressure induces the flow of the chemical agent through and out of the micropipette 2a .
- the flow of agent in the medium reaches the top edge of the cell viewing substrate 1 and, as it progresses over the edge, it has imparted thereto via the wall Ia and the wall edge a concentration gradient of chemical agent , which advances into the portion of the upper surface of the cell viewing substrate 1 where the cells are located .
- the position of the micropipette 2a and the pressure at which the chemical agent is delivered as described above result in a flow of chemical agent , and a moving gradient of concentration of the agent , which is generally perpendicular to the path of the moving cells on the surface of the cell viewing substrate .
- the concentration gradient that forms has two phases ( Figure 7 ) .
- the first phase spans the 17 ⁇ m distance from the tip of the micropipette 2a to the upper surface of the cell viewing substrate 1. This phase typically has a high diffusion rate .
- the second phase spans from the edge of cell viewing substrate 1 across the upper surface of the cell viewing substrate 1.
- This phase typically has a slower diffusion rate .
- the dam wall Ia provides for the rapid establishment of a stable and steep gradient , typically within 20 seconds of micropipette agent release, that results in a slow rate of diffusion of growth factors across the upper surface of the cell viewing substrate .
- the cell motility is typically then monitored by time-lapse video microscopy for approximately 1 hour .
- the apparatus shown in Figures 1 and 2 may be used with a single micropipette as shown in Figures IA and IB, with multiple micropipettes as shown in Figure 2A, or with a broad tipped pipette as shown in Figure 2B .
- One advantage of using multiple micropipettes or a broad tipped pipette is the resultant increase in the area of the concentration gradient that the cells are exposed to . This increases the number of cells that can be monitored, and therefore, the throughput of an experiment .
- FIG. 3 , 4 and 8 where like reference numerals are used to denote similar or like parts , another embodiment of the apparatus for monitoring cell motility is shown .
- This form is typically suitable for monitoring slow moving cell types , such as cancer cells .
- the apparatus shown comprises a chamber 3 with two optically-transparent substrates , an upper cell viewing substrate 1 , as shown in Figure 3A and a lower substrate 2 as shown in Figure 3B .
- the substrates are microfabricated to contain either apertures Ia or channels 2a .
- the substrates are then bonded together either permanently or non-permanently to form a sealed unit as shown Figure 3C .
- the cell viewing substrate 1 serves as a cover and to enclose the channels 2a .
- the cell viewing substrate 1 contains apertures Ia that overlay the termini of the channels 2a in the lower substrate .
- the channels 2a are connected to an inlet 6, which connects to a compressor (not shown) and allows the delivery of a chemical agent to the cell viewing substrate 1 ( Figures 3A and 3C) .
- Figure 3D shows a detailed view of the relationship between an aperture Ia in the cell viewing substrate and the opening 2b of a channel 2a in the lower substrate that combine to direct the chemical agent to the upper surface of the cell viewing substrate 1.
- the side wall of an aperture causes the flow of the chemical agent through the aperture to form a concentration gradient 7 which then fans over the top edge of the aperture as shown in Figure 3E .
- Figure 8 shows the concentration profile of a chemical agent obtained using the apparatus as shown in Figure 3.
- the apertures Ia and the termini of the channels 2a may be provided with various shapes , several examples of which are shown in Figure 3F .
- Figure 3G shows an embodiment in which the aperture Ia is provided in the form of an elongate groove within the cell viewing substrate 1.
- the aperture ( s ) Ia can be positioned at more than one location along and in the cell viewing substrate relative to the channels 2a as shown in Figure 3H .
- Figure 4 depicts alternative configurations for the apparatus , including Figure 4A : a single channel 2a within a single chamber 3 ; Figure 4B : multiple channels 2a within a single chamber 3 ; Figure 4C : multiple channels 2a within individual sub- chambers 3 ; Figure 4D : groups of two or more channels 2a within a single sub-chamber 3 ; and Figure 4E : groups of two or more channels 2a within individual sub-chambers 3.
- Figure 5 shows another embodiment of the apparatus for monitoring cell motility .
- Figure 5C shows the assembled apparatus .
- Figure 5A shows an upper substrate 1 supporting a chamber 3 thereover, and with apertures Ia formed in the substrate .
- Figure 5B shows a lower substrate 2 with channels 2a defined therein .
- the termini 2b of the channels 2a in this embodiment are triangular in shape
- the apertures Ia are l ⁇ m in diameter .
- the channels can vary from l ⁇ m x l ⁇ m up to 50 ⁇ m x 50 ⁇ m in size without effecting the concentration profile .
- the apertures are spaced on the cell viewing substrate 1 at least 40 ⁇ m apart, for embodiments where the channels 2a are 50 ⁇ m x 50 ⁇ m in size .
- Figure 6 shows another embodiment of the apparatus in which the chamber 3 is circular in shape and the inlet 6 from the chemical agent is located in the centre .
- the apertures Ia are located around the periphery of the chamber 3 with radially extending channels 2a extending to each respective aperture Ia from inlet 6.
- Figure 7 shows the steady state concentration profile of a chemical agent formed by diverting the flow of chemical agent using a barrier as described in above and in Figures 1 and 2.
- dam Ia diverts the flow of chemical agent from micropippette 2a to impart a concentration gradient .
- the rate of formation of the gradient, the shape and steepness of the gradient, and/or the stability of the gradient can be modulated .
- Figure 9 shows the concentration profile of a chemical agent as it varies with pressure .
- the Figure indicates that at pressures ranging from 10 , 000 to 400 , 000 Nm "2 the concentration gradient of the chemical agent remains steep, dropping from a concentration of 0.000001M to OM over a 40 ⁇ m distance .
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Clinical Laboratory Science (AREA)
- Cell Biology (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2006208430A AU2006208430A1 (en) | 2005-01-31 | 2006-01-31 | Apparatus and method for monitoring cell motility |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US64808505P | 2005-01-31 | 2005-01-31 | |
US60/648,085 | 2005-01-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2006079185A1 true WO2006079185A1 (en) | 2006-08-03 |
Family
ID=36739987
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/AU2006/000116 WO2006079185A1 (en) | 2005-01-31 | 2006-01-31 | Apparatus and method for monitoring cell motility |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2006208430A1 (en) |
WO (1) | WO2006079185A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008117192A1 (en) * | 2007-03-26 | 2008-10-02 | Koninklijke Philips Electronics N. V. | A chemotaxis assay based on chemotactic agents releasing carrier structures |
KR100896431B1 (en) | 2007-05-31 | 2009-05-12 | 전자부품연구원 | Anti-cancer drug reactivity test method using cancer cell motility analysis |
US7594270B2 (en) | 2004-12-29 | 2009-09-22 | Alert Logic, Inc. | Threat scoring system and method for intrusion detection security networks |
WO2009121137A1 (en) * | 2008-04-01 | 2009-10-08 | Lilian Soon | Method for imaging directional cell migration |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5302515A (en) * | 1992-08-20 | 1994-04-12 | Neuro Probe, Inc. | Chemotactic test apparatus and method |
US5916801A (en) * | 1996-10-31 | 1999-06-29 | Lopinto; Richard William | Nectophotometer |
WO2000007007A1 (en) * | 1998-07-28 | 2000-02-10 | Biometric Imaging, Inc. | Device and method for cell motility assay |
US20030022269A1 (en) * | 2000-11-08 | 2003-01-30 | Gregory Kirk | Method of monitoring cell motility and chemotaxis |
WO2004053465A2 (en) * | 2002-12-09 | 2004-06-24 | Advanced Fluidix Laboratories, Llc | Male fertility assay method and device |
-
2006
- 2006-01-31 WO PCT/AU2006/000116 patent/WO2006079185A1/en not_active Application Discontinuation
- 2006-01-31 AU AU2006208430A patent/AU2006208430A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5302515A (en) * | 1992-08-20 | 1994-04-12 | Neuro Probe, Inc. | Chemotactic test apparatus and method |
US5916801A (en) * | 1996-10-31 | 1999-06-29 | Lopinto; Richard William | Nectophotometer |
WO2000007007A1 (en) * | 1998-07-28 | 2000-02-10 | Biometric Imaging, Inc. | Device and method for cell motility assay |
US20030022269A1 (en) * | 2000-11-08 | 2003-01-30 | Gregory Kirk | Method of monitoring cell motility and chemotaxis |
WO2004053465A2 (en) * | 2002-12-09 | 2004-06-24 | Advanced Fluidix Laboratories, Llc | Male fertility assay method and device |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7594270B2 (en) | 2004-12-29 | 2009-09-22 | Alert Logic, Inc. | Threat scoring system and method for intrusion detection security networks |
WO2008117192A1 (en) * | 2007-03-26 | 2008-10-02 | Koninklijke Philips Electronics N. V. | A chemotaxis assay based on chemotactic agents releasing carrier structures |
KR100896431B1 (en) | 2007-05-31 | 2009-05-12 | 전자부품연구원 | Anti-cancer drug reactivity test method using cancer cell motility analysis |
WO2009121137A1 (en) * | 2008-04-01 | 2009-10-08 | Lilian Soon | Method for imaging directional cell migration |
Also Published As
Publication number | Publication date |
---|---|
AU2006208430A1 (en) | 2006-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US12138626B2 (en) | In situ-generated microfluidic isolation structures, kits and methods of use thereof | |
US11358146B2 (en) | System and method for isolating and analyzing cells | |
US10730045B2 (en) | System and method for performing droplet inflation | |
CN101102847B (en) | Microchannel separation cell using having patterned posts | |
US9784664B2 (en) | Multidimensional hydrodynamic focusing chamber | |
CN107810059B (en) | Freezing and archiving cells on microfluidic devices | |
US9671366B2 (en) | Pipettes, methods of use, and methods of stimulating an object of interest | |
US10471430B2 (en) | Substrate for supporting liquid sample, an assembly comprising such a substrate and use thereof | |
JP2005509883A (en) | Sample tip | |
US20040058407A1 (en) | Reactor systems having a light-interacting component | |
US20080057561A1 (en) | Cell culture treatment apparatus and cell culture treatment method | |
JP5263479B2 (en) | Microchip | |
JP2012228268A (en) | Microfluidic particle-analysis system | |
US8470110B2 (en) | Sample chamber and method for the production thereof | |
JP2014029327A (en) | Fluid control device for microchip, and usage of the same | |
WO2006079185A1 (en) | Apparatus and method for monitoring cell motility | |
WO2003104384A1 (en) | Reactor systems having a light-interacting component | |
US20080254535A1 (en) | Cell Separation Apparatus | |
US20230321659A1 (en) | Microfluidic chip for high-throughput cell pairing and fusion | |
GB2621756A (en) | Microfluidic chip, box body device, and microfluidic device | |
US20090035745A1 (en) | Site-Specific Dosing of Cellular Cultures | |
KR20250053168A (en) | Improvements to the composite wall of the device | |
EP3639925B1 (en) | Droplet generator and generation method | |
WO2025122029A1 (en) | An apparatus for spermatozoa selection and an apparatus for spermatozoa guidance | |
HK1259996A1 (en) | In situ-generated microfluidic isolation structures, kits and methods of use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006208430 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2006208430 Country of ref document: AU Date of ref document: 20060131 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2006208430 Country of ref document: AU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06704798 Country of ref document: EP Kind code of ref document: A1 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 6704798 Country of ref document: EP |